Literature DB >> 8442150

De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.

A G Sheil1, A P Disney, T H Mathew, N Amiss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442150

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  14 in total

1.  Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.

Authors:  M Mansh; M Binstock; K Williams; F Hafeez; J Kim; D Glidden; R Boettger; S Hays; J Kukreja; J Golden; M M Asgari; P Chin-Hong; J P Singer; S T Arron
Journal:  Am J Transplant       Date:  2015-09-03       Impact factor: 8.086

Review 2.  The role of immunosuppression in lymphoma formation.

Authors:  I Penn
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulin.

Authors:  Joost G K van der Hem; Liesbeth C de Wreede; Anneke Brand; Hendrik Veelken; J H Frederik Falkenburg; Constantijn J M Halkes
Journal:  Haematologica       Date:  2017-07-13       Impact factor: 9.941

4.  Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.

Authors:  G V Mazariegos; H Ramos; R Shapiro; A Zeevi; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

5.  Acute leukaemia following renal transplantation.

Authors:  M Subar; R Gucalp; J Benstein; G Williams; P H Wiernik
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

Review 6.  Malignancy in kidney transplant recipients.

Authors:  Anil Kapoor
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  [Malignant neoplasms and kidney transplantation].

Authors:  H Heynemann; A Hamza; S Wagner; R Hoda; A Schumann; P Fornara
Journal:  Urologe A       Date:  2009-12       Impact factor: 0.639

Review 8.  Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.

Authors:  Alex Gutierrez-Dalmau; Josep M Campistol
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Post-transplant malignancy: the role of immunosuppression.

Authors:  I Penn
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.228

10.  CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.

Authors:  Matthew J Bottomley; Paul N Harden; Kathryn J Wood
Journal:  J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.